Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=arnaLatest Financial News for Arena Pharmaceuticals, Inc.en-usThu, 24 Dec 2009 00:01:59 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh84177_2009-12-24_00-01-59_n23166204_newsml&rpc=44&type=marketsNewsyahoo_finance/2158892324Thu, 24 Dec 2009 00:01:59 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091223/us_arena_pharma_merck.html?.v=1Merck & Co. is ending a collaboration with Arena Pharmaceuticals Inc., Arena said Wednesday, following the failure of an atherosclerosis drug.yahoo_finance/380930553Wed, 23 Dec 2009 22:12:11 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091223/arna8-k.htmlyahoo_finance/536454765Wed, 23 Dec 2009 21:12:10 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/mp#arnayahoo_finance/2956297683Wed, 23 Dec 2009 21:09:44 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091223/la30253.html?.v=1Arena Pharmaceuticals, Inc. announced today Merck and Co., Inc.'s decision to discontinue development of MK-1903, an investigational niacin receptor agonist to treat atherosclerosis being developed under its research collaboration with Arena.yahoo_finance/2260150044Wed, 23 Dec 2009 21:05:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/cnbc/rss/SIG=11hsafmf2/*http%3A//www.cnbc.com/id/34574370/site/14081545?__source=yahoo%7Cheadline%7Cquote%7Ctext%7C&par=yahooyahoo_finance/816694269Wed, 23 Dec 2009 17:08:55 Etc/GMThttp://us.rd.yahoo.com/finance/external/video/ts/rss/SIG=12i5ctde1/*http%3A//www.thestreet.com/_yahoo/story/10651098/1/top-2010-stocks-under-10.html?cm_ven=YAHOOV&cm_cat=FREE&cm_ite=NAyahoo_finance/3176138752Tue, 22 Dec 2009 20:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/video/ts/rss/SIG=12mrn6ria/*http%3A//www.thestreet.com/_yahoo/story/10651098/1/top-stocks-under-10-for-2010.html?cm_ven=YAHOOV&cm_cat=FREE&cm_ite=NAyahoo_finance/3008196320Tue, 22 Dec 2009 20:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh70781_2009-12-22_18-38-34_n2255601_newsml&rpc=44&type=marketsNewsyahoo_finance/3255395639Tue, 22 Dec 2009 18:38:34 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091222/us_arena_pharma_lorcaserin.html?.v=2The first of a new class of obesity drugs moved one step closer to the market Tuesday, as Arena Pharmaceuticals Inc. said it filed for approval of its drug candidate lorcaserin.yahoo_finance/1717896707Tue, 22 Dec 2009 16:01:42 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12vtab782/*http%3A//www.thestreet.com/_yahoo/story/10651030/1/arena-pharma-amkor-early-volume-plays.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/656040768Tue, 22 Dec 2009 14:12:42 Etc/GMThttp://us.rd.yahoo.com/finance/external/FoxBusiness.com/rss/SIG=12v4bgc9s/*http%3A//www.foxbusiness.com/story/markets/early-morning-movers-amkor-technology-interactive/yahoo_finance/509067897Tue, 22 Dec 2009 14:04:44 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=11kitjnkn/*http%3A//www.marketwatch.com/News/Story/Story.aspx?guid=%7b110BBC61-9604-461A-8C68-45B2C843E977%7d&siteid=yhoof2yahoo_finance/2157923704Tue, 22 Dec 2009 14:04:20 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091222/la29064.html?.v=1Arena Pharmaceuticals, Inc. announced today that it has submitted a New Drug Application to the US Food and Drug Administration for lorcaserin, Arena's internally discovered and developed drug candidate for weight management, including weight loss and maintenance of weight loss.yahoo_finance/3963597315Tue, 22 Dec 2009 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091217/us_movers_roundup_harley_davidson.html?.v=1Shares of Harley-Davidson Inc. declined after an analyst recommended investors sell the motorcycle maker's stock, saying bike sales fell as much as 40 percent in October and November and demand remains uncertain.yahoo_finance/4106822763Thu, 17 Dec 2009 19:14:53 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091217/us_arena_pharmaceuticals_mover.html?.v=1Shares of Arena Pharmaceuticals Inc. fell Thursday after a Jefferies & Co. analyst started coverage on the drug developer with an upbeat but cautious view on the obesity drug candidate lorcaserin.yahoo_finance/1445153484Thu, 17 Dec 2009 17:42:02 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/ud?s=ARNAyahoo_finance/408603031Thu, 17 Dec 2009 11:51:54 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12tiak2vi/*http%3A//www.thestreet.com/_yahoo/story/10645419/1/biotech-calendar-upcoming-fda-dates.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/1361860995Tue, 15 Dec 2009 10:05:12 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091211/arna8-k.htmlyahoo_finance/359935784Fri, 11 Dec 2009 20:08:12 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091210/la24572.html?.v=1Arena Pharmaceuticals, Inc. reported that positive data from a clinical trial evaluating the abuse potential of lorcaserin were presented in a poster session at the 48th Annual Meeting of the American College of Neuropsychopharmacology.yahoo_finance/4097416755Fri, 11 Dec 2009 00:00:00 Etc/GMT